Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy

Lisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, Tontanai Numbenjapon, Jennifer Bennitt, Daniel Kim, David Smith, George McNamara, Zaid Al-Kadhimi, Joseph Rosenthal, Stephen J. Forman, Michael C. Jensen, Laurence J. N. Cooper

Blood (2006) 107 (7): 2643–2652.

https://doi.org/10.1182/blood-2005-09-3904

Published: 2006

Includes: Multimedia, Supplemental data

Journal Articles

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1

Laurence J. N. Cooper, Zaid Al-Kadhimi, Lisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, Adrian Castro, Wen-Chung Chang, Sergio Gonzalez, David Smith, Stephen J. Forman, Michael C. Jensen

Blood (2005) 105 (4): 1622–1631.

https://doi.org/10.1182/blood-2004-03-1208

Published: 2005

Journal Articles

Cord Blood-Derived T Cells Can Be Genetically Engineered to Be B-Lineage All-Specific: Towards Adoptive Immunotherapy after Umbilical Cord Blood Transplantation.

Laurence J.N. Cooper, MD, PhD, Lisa Marie Serrano, BA, Zaid Al-Kadhimi, MD, Simon Olivares, BS, Sergio Gonzalez, BA, Timothy Pfeiffer, BS, Joseph Rosenthal, MD, Steven J. Forman, MD, Michael C. Jensen, MD

Blood (2004) 104 (11): 48.

https://doi.org/10.1182/blood.V104.11.48.48

Published: 2004

Journal Articles

T Cells Genetically Modified to Be CD19-Specific with Improved Potential for Trafficking and Activation.

Zaid Al-Kadhimi, MD, Lisa Marie Serrano, BA, Simon Olivares, BS, Sergio Gonzalez, BA, Timothy Pfeiffer, BS, Reena Vishwanath, BA, Michael C. Jensen, MD, Steven J. Forman, MD, Laurence J.N. Cooper, MD, PhD

Blood (2004) 104 (11): 1748.

https://doi.org/10.1182/blood.V104.11.1748.1748

Published: 2004

Journal Articles

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Laurence J. N. Cooper, Max S. Topp, Lisa Marie Serrano, Sergio Gonzalez, Wen-Chung Chang, Araceli Naranjo, Christine Wright, Leslie Popplewell, Andrew Raubitschek, Stephen J. Forman, Michael C. Jensen

Blood (2003) 101 (4): 1637–1644.

https://doi.org/10.1182/blood-2002-07-1989

Published: 2003

NARROW

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1

Cord Blood-Derived T Cells Can Be Genetically Engineered to Be B-Lineage All-Specific: Towards Adoptive Immunotherapy after Umbilical Cord Blood Transplantation.

T Cells Genetically Modified to Be CD19-Specific with Improved Potential for Trafficking and Activation.

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Email alerts

ASH Publications

American Society of Hematology

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1

Cord Blood-Derived T Cells Can Be Genetically Engineered to Be B-Lineage All-Specific: Towards Adoptive Immunotherapy after Umbilical Cord Blood Transplantation.

T Cells Genetically Modified to Be CD19-Specific with Improved Potential for Trafficking and Activation.

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only